ADME of Bevenopran (CB-5945) in Healthy Male Subjects (QBR115178)

• Research type

  Research Study

• Full title

  A phase 1, open-label study of the absorption, distribution, metabolism and excretion and the absolute bioavailability of Bevenopran (CB-5945) in healthy male subjects

• IRAS ID

  132939

• Contact name

  Stuart Mair

• Contact email

  stuart.mair@quotientbioresearch.com

• Sponsor organisation

  Cubist Pharmaceuticals Inc.

• Eudract number

  2013-002218-12

• ISRCTN Number

  To be registered

• REC name

  Wales REC 1

• REC reference

  13/WA/0181

• Date of REC Opinion

  26 Jun 2013

• REC opinion

  Further Information Favourable Opinion